Bacteria Wins First Round Against Inflammatory Bowel Disease

December 31, 2009 By Ann Perry
ARS microbiologist Terry Whitehead is part of a team that found and altered a microbe so it might one day help treat inflammatory bowel disease and other chronic intestinal diseases in people.

( -- A group of British scientists and their Agricultural Research Service (ARS) colleague used a benign bacterium from the human gut to develop a microbe that someday might help treat inflammatory bowel disease (IBD) and other chronic intestinal diseases.

IBD erodes the delicate lining of the intestine, and its symptoms—often severe—include cramping, abdominal pain and other gastrointestinal discomfort. IBD cannot be cured, and current treatments can have adverse side effects. Medical practitioners and patients are anxious for the development of more effective therapies, particularly protocols that deliver drugs directly to the intestine.

So ARS microbiologist Terry Whitehead, who works at the National Center for Agricultural Utilization Research in Peoria, Ill., and his partners began searching for a solution. Simon Carding, who works at the Institute of Food Research and the University of East Anglia in Norwich, Great Britain, led the research project with Zaed Hamady, who works at the University of Leeds in Great Britain and St. James University Hospital, also in Leeds.

The group focused on the Bacteroides ovatus (B. ovatus), which is one of an assortment of intestinal microflora in humans. B. ovatus thrives in the oxygen-free environment of the large intestine, where it breaks down xylan—a fiber found in plants—and other sugars for energy and growth.

The team created a strain of B. ovatus that used xylan to induce secretion of human keratinocyte growth factor, a protein that helps repair and restore the intestine’s delicate lining. This increased the ability of the intestine to repair IBD-inflicted damage.

The researchers found that IBD-affected mice treated with oral doses of xylan and the engineered strain of B. ovatus had intestinal tissues that healed more rapidly. This group of mice also lost less weight and had lower levels of rectal bleeding. In addition, dosing mice with B. ovatus provided protection from induced IBD and limited the development of subsequent intestinal inflammation.

An abstract of this research was published online in the journal Gut.

Explore further: Genetically engineered bacteria are sweet success against IBD

Related Stories

A spoonful of sugar makes the medicine go to work

January 22, 2007

There will soon be no more bitter pills to swallow, thanks to new research by University of Leeds scientists (UK): a spoonful of sugar will be all we need for our bodies to make their own medicine.

Enzyme involved in inflammatory bowel disease discovered

June 2, 2009

Researchers at Penn State College of Medicine, working with biochemists, geneticists and clinicians at the University of Bern, Switzerland and in the United Kingdom, have discovered an enzyme that has a key role in inflammatory ...

The bowels of infection

October 21, 2009

Current research suggests that latent cytomegalovirus (CMV) infection may exacerbate inflammatory bowel disease (IBD). The related report by Onyeagocha et al, "Latent cytomegalovirus infection exacerbates experimental colitis," ...

Recommended for you

Ten months in the air without landing

October 27, 2016

Common swifts are known for their impressive aerial abilities, capturing food and nest material while in flight. Now, by attaching data loggers to the birds, researchers reporting in the Cell Press journal Current Biology ...


Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Jan 01, 2010
It would be interesting to see this applied to canines. One of my greyhounds died from IBD and apparently it is fairly common in dogs.
not rated yet Jan 02, 2010
I always get a good laugh when I hear some "scientist" say that something "cannot be cured".
So what are they doing working with it?
Perhaps they would do better dealing with something that CAN be cured and leave the CAN'TS to more open minded people.
ARS indeed!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.